** Job Advert** Oncology & Haematology Specialist 8a Pharmacist at University Hospitals of Leicester

Are you looking to develop yourself and further your career in one of the largest Trusts in the country?

We are looking to recruit an enthusiastic Oncology & Haematology Specialist Pharmacist to join our friendly team at Leicester. You will work within a team of Pharmacists and Technicians providing clinical, technical and prescribing support to Haematology, Oncology, Clinical Trials and Aseptic Services.

To find out more visit https://www.jobs.nhs.uk/xi/vacancy/916638077 – closing date Aug 1st

For further details / informal visits contact:
Lead Oncology Pharmacists: Usha Goyal, on 07943 555663 or by e-mail at [email protected] or Anna Tipping [email protected] 07872143003

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article